HEMATOLOGIC DISEASES
Clinical trials for HEMATOLOGIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shield young transplant patients from dangerous immune attack
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers or disorders. About 43 participants will receive vo…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
CRISPR treatment frees kids from lifelong blood transfusions
Disease control OngoingThis study tests a one-time gene-editing treatment (CTX001) in 16 children with transfusion-dependent beta-thalassemia, a severe blood disorder. The therapy uses the child's own stem cells, modified with CRISPR-Cas9, to produce healthy red blood cells. The main goal is to see if …
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
CRISPR gene therapy: a Long-Term look at safety for blood disease patients
Disease control ENROLLING_BY_INVITATIONThis study follows 160 children and adults with beta-thalassemia or sickle cell disease who received a one-time treatment of their own CRISPR-edited stem cells (CTX001). Researchers will monitor participants for years to check for side effects, new cancers, and how well the thera…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Massive study tracks health of 32,000 gulf oil spill cleanup workers
Knowledge-focused OngoingThis study follows over 32,000 people who helped clean up the 2010 Deepwater Horizon oil spill in the Gulf of Mexico. Researchers want to see if exposure to oil and chemicals during cleanup leads to long-term health problems like heart disease, cancer, or lung issues. Participant…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC
-
Massive data collection aims to fuel future medical breakthroughs
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers medical records, test results, and treatment information from up to 10,000 people with various blood and heart conditions, as well as stem cell donors. The goal is to create a large database that researchers can use to develop new ideas for future studies. Part…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Frozen testicle tissue may restore fertility in men after cancer
Knowledge-focused OngoingThis early study tests whether frozen testicular tissue can be grafted back into men to produce sperm. It involves 5 men aged 40 or older who are having routine groin surgery. The goal is to see if this approach could one day help boys and men who lose fertility due to cancer tre…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Bone marrow transplant tissue study aims to unlock cancer secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects tissue samples from people receiving bone marrow transplants and their donors. Researchers will analyze these samples to identify genes and proteins that may play a role in cancer development and progression. The goal is to better understand transplant outcome…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC
-
Muscle health may predict stem cell transplant success
Knowledge-focused OngoingThis study looks at how blood cancers and stem cell transplants impact muscle function in 144 patients. Researchers want to see if muscle problems can help predict complications like infections, hospital stays, or survival. The goal is to better understand recovery and guide futu…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 11, 2026 20:54 UTC
-
New tech aims to cut errors when patients are moved between hospitals
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new digital tool that helps hospitals share patient information more reliably when a person is transferred from one hospital to another. The goal is to reduce medical mistakes and improve safety. About 1,000 adults being transferred to a major hospital will tak…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC